{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:53:52Z","timestamp":1777413232900,"version":"3.51.4"},"reference-count":76,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/100009377","name":"Scientific Research Project of the Hunan Provincial Department of Education","doi-asserted-by":"publisher","award":["20K106"],"award-info":[{"award-number":["20K106"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Project of the Hunan Provincial Health Committee","doi-asserted-by":"publisher","award":["D202302048902"],"award-info":[{"award-number":["D202302048902"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Canopy FGF signaling regulator 2 (CNPY2) is a novel angiogenic growth factor. In recent\nyears, increasing evidence highlights that CNPY2 has important functions in health and disease.\nMany new blood vessels need to be formed to meet the nutrient supply in the process of tumor\ngrowth. CNPY2 can participate in the development of tumors by promoting angiogenesis. CNPY2\nalso enhances neurite outgrowth in neurologic diseases and promotes cell proliferation and tissue\nrepair, thereby improving cardiac function in cardiovascular diseases. Regrettably, there are few\nstudies on CNPY2 in various diseases. At the same time, its biological function and molecular\nmechanism in the process and development of disease are still unclear. This paper reviews the recent\nstudies on CNPY2 in cervical cancer, renal cell carcinoma, prostate cancer, colorectal cancer,\nlung cancer, gastric cancer, hepatocellular carcinoma, cerebral ischemia-reperfusion injury, spinal\ncord ischemia-reperfusion injury, Parkinson\u2019s disease, ischemic heart disease, myocardial ischemiareperfusion\ninjury, myocardial infarction, heart failure, and non-alcoholic fatty liver disease. The\nbiological function and molecular mechanism of CNPY2 in these diseases have been summarized in\nthis paper. Many drugs that play protective roles in tumors, cardiovascular diseases, non-alcoholic\nfatty liver disease, and neurologic diseases by targeting CNPY2, have also been summarized in this\npaper. In addition, the paper also details the biological functions and roles of canopy FGF signaling\nregulator 1 (CNPY1), canopy FGF signaling regulator 3 (CNPY3), canopy FGF signaling regulator\n4 (CNPY4), and canopy FGF signaling regulator 5 (CNPY5). The mechanism and function of\nCNPY2 should be continued to study in order to accelerate disease prevention in the future.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557523666230601094149","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T09:59:57Z","timestamp":1685613597000},"page":"391-402","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Progress in Research on CNPY2 in Diseases"],"prefix":"10.2174","volume":"24","author":[{"given":"Ke-qian","family":"Chen","sequence":"first","affiliation":[{"name":"Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hengyang Medical School, University of\nSouth China, Hengyang, 421001, China"},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New\nDrug Study, School of Pharmaceutical Science, University of South China, Hengyang, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hengyang Medical School, University of South China, Hengyang 421001, China"},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New\nDrug Study, School of Pharmaceutical Science, University of South China, Hengyang, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong-bao","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hengyang Medical School, University of\nSouth China, Hengyang, 421001, China"},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New\nDrug Study, School of Pharmaceutical Science, University of South China, Hengyang, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-zhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hengyang Medical School, University of\nSouth China, Hengyang, 421001, China"},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New\nDrug Study, School of Pharmaceutical Science, University of South China, Hengyang, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/pro.3635","volume":"28","author":"Schildknegt D.","year":"2019","unstructured":"Schildknegt D.; Lodder N.; Pandey A.; Egmond M.; Pena F.; Braakman I.; Sluijs P.; van der Sluijs P.; Characterization of CNPY5 and its family members. Protein Sci  2019,28(7),1276-1289","journal-title":"Protein Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cub.2006.01.055","volume":"16","author":"Hirate Y.","year":"2006","unstructured":"Hirate Y.; Okamoto H.; Canopy1, a novel regulator of FGF signaling around the midbrain-hindbrain boundary in zebrafish. Curr Biol  2006,16(4),421-427","journal-title":"Curr Biol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"9881","DOI":"10.1073\/pnas.1017248108","volume":"108","author":"Matsui T.","year":"2011","unstructured":"Matsui T.; Thitamadee S.; Murata T.; Kakinuma H.; Nabetani T.; Hirabayashi Y.; Hirate Y.; Okamoto H.; Bessho Y.; Canopy1, a positive feedback regulator of FGF signaling, controls progenitor cell clustering during Kupffer\u2019s vesicle organogenesis. Proc Natl Acad Sci  2011,108(24),9881-9886","journal-title":"Proc Natl Acad Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"e111370","DOI":"10.1371\/journal.pone.0111370","volume":"9","author":"Hatta K.","year":"2014","unstructured":"Hatta K.; Guo J.; Ludke A.; Dhingra S.; Singh K.; Huang M.L.; Weisel R.D.; Li R.K.; Expression of CNPY2 in mouse tissues: Quantification and localization. PLoS One  2014,9(11),e111370","journal-title":"PLoS One"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"12602","DOI":"10.1074\/jbc.M112.341248","volume":"287","author":"Do H.T.","year":"2012","unstructured":"Do H.T.; Tselykh T.V.; M\u00e4kel\u00e4 J.; Ho T.H.; Olkkonen V.M.; Bornhauser B.C.; Korhonen L.; Zelcer N.; Lindholm D.; Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip\/Idol and the Canopy2 (Cnpy2)\/Mylip-interacting saposin-like protein (Msap). J Biol Chem  2012,287(16),12602-12611","journal-title":"J Biol Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/eji.202149612","volume":"52","author":"Ghait M.","year":"2022","unstructured":"Ghait M.; Husain R.A.; Duduskar S.N.; Haack T.B.; Rooney M.; G\u00f6hrig B.; Bauer M.; Rubio I.; Deshmukh S.D.; The TLR\u2010chaperone CNPY3 is a critical regulator of NLRP3\u2010inflammasome activation. Eur J Immunol  2022,52(6),907-923","journal-title":"Eur J Immunol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1053\/j.gastro.2019.05.010","volume":"157","author":"Xiao L.","year":"2019","unstructured":"Xiao L.; Li X.X.; Chung H.K.; Kalakonda S.; Cai J.Z.; Cao S.; Chen N.; Liu Y.; Rao J.N.; Wang H.Y.; Gorospe M.; Wang J.Y.; RNA-binding protein HuR regulates paneth cell function by altering membrane localization of TLR2 via post-transcriptional control of CNPY3. Gastroenterology  2019,157(3),731-743","journal-title":"Gastroenterology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ajhg.2018.01.004","volume":"102","author":"Mutoh H.","year":"2018","unstructured":"Mutoh H.; Kato M.; Akita T.; Shibata T.; Wakamoto H.; Ikeda H.; Kitaura H.; Aoto K.; Nakashima M.; Wang T.; Ohba C.; Miyatake S.; Miyake N.; Kakita A.; Miyake K.; Fukuda A.; Matsumoto N.; Saitsu H.; Biallelic variants in CNPY3, encoding an endoplasmic reticulum chaperone, cause early-onset epileptic encephalopathy. Am J Hum Genet  2018,102(2),321-329","journal-title":"Am J Hum Genet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.1074\/jbc.M116.755538","volume":"292","author":"Morales C.","year":"2017","unstructured":"Morales C.; Li Z.; Drosophila canopy b is a cochaperone of glycoprotein 93. J Biol Chem  2017,292(16),6657-6666","journal-title":"J Biol Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ncomms1070","volume":"1","author":"Liu B.","year":"2010","unstructured":"Liu B.; Yang Y.; Qiu Z.; Staron M.; Hong F.; Li Y.; Wu S.; Li Y.; Hao B.; Bona R.; Han D.; Li Z.; Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone. Nat Commun  2010,1(1),79","journal-title":"Nat Commun"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/s41467-022-30186-x","volume":"13","author":"Lo M.","year":"2022","unstructured":"Lo M.; Sharir A.; Paul M.D.; Torosyan H.; Agnew C.; Li A.; Neben C.; Marangoni P.; Xu L.; Raleigh D.R.; Jura N.; Klein O.D.; CNPY4 inhibits the Hedgehog pathway by modulating membrane sterol lipids. Nat Commun  2022,13(1),2407","journal-title":"Nat Commun"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e30044","DOI":"10.1097\/MD.0000000000030044","volume":"101","author":"Li J.W.","year":"2022","unstructured":"Li J.W.; Huang Q.R.; Mo L.G.; CNPY4 is a potential promising prognostic-related biomarker and correlated with immune infiltrates in gliomas. Medicine  2022,101(33),e30044","journal-title":"Medicine"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"166826","DOI":"10.1016\/j.jmb.2021.166826","volume":"433","author":"Sowa S.T.","year":"2021","unstructured":"Sowa S.T.; Moilanen A.; Biterova E.; Saaranen M.J.; Lehti\u00f6 L.; Ruddock L.W.; High-resolution crystal structure of human pERp1, A saposin-like protein involved in IgA, IgM and integrin maturation in the endoplasmic reticulum. J Mol Biol  2021,433(5),166826","journal-title":"J Mol Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"17019","DOI":"10.1073\/pnas.0903036106","volume":"106","author":"van Anken E.","year":"2009","unstructured":"van Anken E.; Pena F.; Hafkemeijer N.; Christis C.; Romijn E.P.; Grauschopf U.; Oorschot V.M.J.; Pertel T.; Engels S.; Ora A.; L\u00e1stun V.; Glockshuber R.; Klumperman J.; Heck A.J.R.; Luban J.; Braakman I.; Efficient IgM assembly and secretion require the plasma cell induced endoplasmic reticulum protein pERp1. Proc Natl Acad Sci USA  2009,106(40),17019-17024","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1073\/pnas.0811591106","volume":"106","author":"Shimizu Y.","year":"2009","unstructured":"Shimizu Y.; Meunier L.; Hendershot L.M.; pERp1 is significantly up-regulated during plasma cell differentiation and contributes to the oxidative folding of immunoglobulin. Proc Natl Acad Sci USA  2009,106(40),17013-17018","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"13480","DOI":"10.1073\/pnas.1904204116","volume":"116","author":"Xiong E.","year":"2019","unstructured":"Xiong E.; Li Y.; Min Q.; Cui C.; Liu J.; Hong R.; Lai N.; Wang Y.; Sun J.; Matsumoto R.; Takahashi D.; Hase K.; Shinkura R.; Tsubata T.; Wang J.Y.; MZB1 promotes the secretion of J-chain\u2013containing dimeric IgA and is critical for the suppression of gut inflammation. Proc Natl Acad Sci  2019,116(27),13480-13489","journal-title":"Proc Natl Acad Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"21626","DOI":"10.1038\/s41598-020-78293-3","volume":"10","author":"Kapoor T.","year":"2020","unstructured":"Kapoor T.; Corrado M.; Pearce E.L.; Pearce E.J.; Grosschedl R.; MZB1 enables efficient interferon \u03b1 secretion in stimulated plasmacytoid dendritic cells. Sci Rep  2020,10(1),21626","journal-title":"Sci Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"E9630","DOI":"10.1073\/pnas.1809739115","volume":"115","author":"Andreani V.","year":"2018","unstructured":"Andreani V.; Ramamoorthy S.; Pandey A.; Lupar E.; Nutt S.L.; L\u00e4mmermann T.; Grosschedl R.; Cochaperone Mzb1 is a key effector of Blimp1 in plasma cell differentiation and \u03b21-integrin function. Proc Natl Acad Sci  2018,115(41),E9630-E9639","journal-title":"Proc Natl Acad Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1101\/gad.240762.114","volume":"28","author":"Rosenbaum M.","year":"2014","unstructured":"Rosenbaum M.; Andreani V.; Kapoor T.; Herp S.; Flach H.; Duchniewicz M.; Grosschedl R.; MZB1 is a GRP94 cochaperone that enables proper immunoglobulin heavy chain biosynthesis upon ER stress. Genes Dev  2014,28(11),1165-1178","journal-title":"Genes Dev"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41401-020-0489-0","volume":"42","author":"Zhang L.","year":"2021","unstructured":"Zhang L.; Wang Y.; Ju J.; Shabanova A.; Li Y.; Fang R.; Sun J.; Guo Y.; Jin T.; Liu Y.; Li T.; Shan H.; Liang H.; Yang B.; Mzb1 protects against myocardial infarction injury in mice via modulating mitochondrial function and alleviating inflammation. Acta Pharmacol Sin  2021,42(5),691-700","journal-title":"Acta Pharmacol Sin"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"Smyth E.C.","year":"2020","unstructured":"Smyth E.C.; Nilsson M.; Grabsch H.I.; van Grieken N.C.T.; Lordick F.; Gastric cancer. Lancet  2020,396(10251),635-648","journal-title":"Lancet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"Thrift A.P.","year":"2020","unstructured":"Thrift A.P.; El-Serag H.B.; Burden of Gastric Cancer. Clin Gastroenterol Hepatol  2020,18(3),534-542","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.3390\/ijms22126548","volume":"22","author":"Waldum H.","year":"2021","unstructured":"Waldum H.; Fossmark R.; Gastritis, gastric polyps and gastric cancer. Int J Mol Sci  2021,22(12),6548","journal-title":"Int J Mol Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1186\/s12885-021-08829-x","volume":"21","author":"Liu R.","year":"2021","unstructured":"Liu R.; Yang X.; LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p\/CNPY2 axis. BMC Cancer  2021,21(1),1163","journal-title":"BMC Cancer"},{"key":"ref=25","first-page":"35","volume":"15","author":"Fang F.","year":"2018","unstructured":"Fang F.; Hong X.; The expression of CNPY2 in gastric cancer and its relationship with the microvessel density of invasion and metastasis. Chin Med Innov  2018,15(23),35-38","journal-title":"Chin Med Innov"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"Biller L.H.","year":"2021","unstructured":"Biller L.H.; Schrag D.; Diagnosis and treatment of metastatic colorectal cancer. JAMA  2021,325(7),669-685","journal-title":"JAMA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Xi Y.","year":"2021","unstructured":"Xi Y.; Xu P.; Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol  2021,14(10),101174","journal-title":"Transl Oncol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.18632\/aging.101324","volume":"9","author":"Peng J.","year":"2017","unstructured":"Peng J.; Ou Q.; Guo J.; Pan Z.; Zhang R.; Wu X.; Zhao Y.; Deng Y.; Li C.; Wang F.; Li L.; Chen G.; Lu Z.; Ding P.; Wan D.; Fang Y.; Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis. Aging  2017,9(11),2334-2351","journal-title":"Aging"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.18632\/aging.101512","volume":"10","author":"Peng J.","year":"2018","unstructured":"Peng J.; Ou Q.; Pan Z.; Zhang R.; Zhao Y.; Deng Y.; Lu Z.; Zhang L.; Li C.; Zhou Y.; Guo J.; Wan D.; Fang Y.; Serum CNPY2 isoform 2 represents a novel biomarker for early detection of colorectal cancer. Aging  2018,10(8),1921-1931","journal-title":"Aging"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.ajpath.2015.11.012","volume":"186","author":"Yan P.","year":"2016","unstructured":"Yan P.; Gong H.; Zhai X.; Feng Y.; Wu J.; He S.; Guo J.; Wang X.; Guo R.; Xie J.; Li R.K.; Decreasing CNPY2 expression diminishes colorectal tumor growth and development through activation of p53 pathway. Am J Pathol  2016,186(4),1015-1024","journal-title":"Am J Pathol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.12688\/f1000research.22926.1","volume":"9","author":"Harada K.","year":"2020","unstructured":"Harada K.; Rogers J.E.; Iwatsuki M.; Yamashita K.; Baba H.; Ajani J.A.; Recent advances in treating oesophageal cancer. F1000 Res  2020,9,1189","journal-title":"F1000 Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.humpath.2017.06.003","volume":"66","author":"He J.Z.","year":"2017","unstructured":"He J.Z.; Wu Z.Y.; Wang S.H.; Ji X.; Yang C.X.; Xu X.E.; Liao L.D.; Wu J.Y.; Li E.M.; Zhang K.; Xu L.Y.; A decision tree\u2013based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma. Hum Pathol  2017,66,115-125","journal-title":"Hum Pathol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"Cohen P.A.","year":"2019","unstructured":"Cohen P.A.; Jhingran A.; Oaknin A.; Denny L.; Cervical cancer. Lancet  2019,393(10167),169-182","journal-title":"Lancet"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1158\/1078-0432.CCR-20-2833","volume":"27","author":"Ferrall L.","year":"2021","unstructured":"Ferrall L.; Lin K.Y.; Roden R.B.S.; Hung C.F.; Wu T.C.; Cervical cancer immunotherapy: Facts and hopes. Clin Cancer Res  2021,27(18),4953-4973","journal-title":"Clin Cancer Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ygyno.2012.03.047","volume":"126","author":"de Freitas A.C.","year":"2012","unstructured":"de Freitas A.C.; Gurgel A.P.A.D.; Chagas B.S.; Coimbra E.C.; do Amaral C.M.M.; Susceptibility to cervical cancer: An overview. Gynecol Oncol  2012,126(2),304-311","journal-title":"Gynecol Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s13187-013-0486-9","volume":"28","author":"Akram M.","year":"2013","unstructured":"Akram M.; Mini-review on glycolysis and cancer. J Cancer Educ  2013,28(3),454-457","journal-title":"J Cancer Educ"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbrc.2021.02.116","volume":"551","author":"Tian T.","year":"2021","unstructured":"Tian T.; Dong Y.; Zhu Y.; Chen Y.; Li X.; Kuang Q.; Liu X.; Li P.; Li J.; Zhou L.; Hypoxia-induced CNPY2 upregulation promotes glycolysis in cervical cancer through activation of AKT pathway. Biochem Biophys Res Commun  2021,551,63-70","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.ejso.2013.11.008","volume":"40","author":"Wang W.","year":"2014","unstructured":"Wang W.; Lin H.; Zhou L.; Zhu Q.; Gao S.; Xie H.; Liu Z.; Xu Z.; Wei J.; Huang X.; Zheng S.; MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Eur J Surg Oncol  2014,40(11),1586-1594","journal-title":"Eur J Surg Oncol"},{"key":"ref=39","first-page":"646","volume":"43","author":"Wang H.","year":"2020","unstructured":"Wang H.; Kanmangne D.; Li R.; Qian Z.; Xia X.; Wang X.; Wang T.; miR 30a 3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2. Oncol Rep  2020,43(2),646-654","journal-title":"Oncol Rep"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.biopha.2018.04.123","volume":"103","author":"Yu D.","year":"2018","unstructured":"Yu D.; Qin Y.; Jun-qiang L.; Shun-lin G.; CNPY2 enhances resistance to apoptosis induced by cisplatin via activation of NF-\u03baB pathway in human non-small cell lung cancer. Biomed Pharmacother  2018,103,1658-1663","journal-title":"Biomed Pharmacother"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/cbin.10961","volume":"42","author":"Dou Y.","year":"2018","unstructured":"Dou Y.; Lei J.Q.; Guo S.L.; Zhao D.; Yue H.M.; Yu Q.; The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT\/GSK3\u03b2 pathway in non-small cell lung cancer. Cell Biol Int  2018,42(8),959-964","journal-title":"Cell Biol Int"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbrc.2021.01.017","volume":"541","author":"Lo L.H.","year":"2021","unstructured":"Lo L.H.; Lam C.Y.; To J.C.; Chiu C.H.; Keng V.W.; Sleeping Beauty insertional mutagenesis screen identifies the pro-metastatic roles of CNPY2 and ACTN2 in hepatocellular carcinoma tumor progression. Biochem Biophys Res Commun  2021,541,70-77","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.3390\/cancers13143613","volume":"13","author":"Kakehashi A.","year":"2021","unstructured":"Kakehashi A.; Suzuki S.; Shiota M.; Raymo N.; Gi M.; Tachibana T.; Stefanov V.; Wanibuchi H.; Canopy Homolog 2 as a novel molecular target in hepatocarcinogenesis. Cancers  2021,13(14),3613","journal-title":"Cancers"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/hep.32318","volume":"76","author":"Hong F.","year":"2022","unstructured":"Hong F.; Lin C.Y.; Yan J.; Dong Y.; Ouyang Y.; Kim D.; Zhang X.; Liu B.; Sun S.; Gu W.; Li Z.; Canopy Homolog 2 contributes to liver oncogenesis by promoting unfolded protein response\u2013dependent destabilization of tumor protein P53. Hepatology  2022,76(6),1587-1601","journal-title":"Hepatology"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1159\/000495048","volume":"50","author":"Wang D.","year":"2018","unstructured":"Wang D.; Wang Z.M.; Zhang S.; Wu H.J.; Tao Y.M.; Canopy homolog 2 expression predicts poor prognosis in hepatocellular carcinoma with tumor hemorrhage. Cell Physiol Biochem  2018,50(6),2017-2028","journal-title":"Cell Physiol Biochem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pharmthera.2013.07.003","volume":"140","author":"Shafi A.A.","year":"2013","unstructured":"Shafi A.A.; Yen A.E.; Weigel N.L.; Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Pharmacol Ther  2013,140(3),223-238","journal-title":"Pharmacol Ther"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"17645","DOI":"10.18632\/oncotarget.24824","volume":"9","author":"Ito S.","year":"2018","unstructured":"Ito S.; Ueno A.; Ueda T.; Nakagawa H.; Taniguchi H.; Kayukawa N.; Fujihara-Iwata A.; Hongo F.; Okihara K.; Ukimura O.; CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells. Oncotarget  2018,9(25),17645-17655","journal-title":"Oncotarget"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-020-01266-7","volume":"19","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Zhang Y.; Wang P.; Fu X.; Lin W.; Circular RNAs in renal cell carcinoma: Implications for tumorigenesis, diagnosis, and therapy. Mol Cancer  2020,19(1),149","journal-title":"Mol Cancer"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3390\/biomedicines10061330","volume":"10","author":"Swiatkowska A.","year":"2022","unstructured":"Swiatkowska A.; p53 and its isoforms in renal cell carcinoma\u2014do they matter? Biomedicines  2022,10(6),1330","journal-title":"Biomedicines"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbrc.2017.02.095","volume":"485","author":"Taniguchi H.","year":"2017","unstructured":"Taniguchi H.; Ito S.; Ueda T.; Morioka Y.; Kayukawa N.; Ueno A.; Nakagawa H.; Fujihara A.; Ushijima S.; Kanazawa M.; Hongo F.; Ukimura O.; CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53. Biochem Biophys Res Commun  2017,485(2),267-271","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jmri.23580","volume":"36","author":"von Knobelsdorff-Brenkenhoff F.","year":"2012","unstructured":"von Knobelsdorff-Brenkenhoff F.; Schulz-Menger J.; Cardiovascular magnetic resonance imaging in ischemic heart disease. J Magn Reson Imaging  2012,36(1),20-38","journal-title":"J Magn Reson Imaging"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/cvr\/cvv010","volume":"105","author":"Guo J.","year":"2015","unstructured":"Guo J.; Zhang Y.; Mihic A.; Li S.H.; Sun Z.; Shao Z.; Wu J.; Weisel R.D.; Li R.K.; A secreted protein (Canopy 2, CNPY2) enhances angiogenesis and promotes smooth muscle cell migration and proliferation. Cardiovasc Res  2015,105(3),383-393","journal-title":"Cardiovasc Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"806216","DOI":"10.3389\/fphar.2022.806216","volume":"13","author":"Chen Z.","year":"2022","unstructured":"Chen Z.; Wu J.; Li S.; Liu C.; Ren Y.; Inhibition of myocardial cell apoptosis is important mechanism for ginsenoside in the limitation of myocardial ischemia\/reperfusion injury. Front Pharmacol  2022,13,806216","journal-title":"Front Pharmacol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10557-021-07280-1","volume":"37","author":"Li Y.Z.","year":"2021","unstructured":"Li Y.Z.; Wu H.; Liu D.; Yang J.; Yang J.; Ding J.W.; Zhou G.; Zhang J.; Zhang D.; cFLIP(L) alleviates myocardial ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress. Cardiovasc Drugs Ther  2021,37(2),225-238","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3892\/ijmm.2019.4123","volume":"43","author":"Cui Y.","year":"2019","unstructured":"Cui Y.; Wang Y.; Liu G.; Protective effect of Barbaloin in a rat model of myocardial ischemia reperfusion injury through the regulation of the CNPY2 PERK pathway. Int J Mol Med  2019,43(5),2015-2023","journal-title":"Int J Mol Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3389\/fphar.2019.00789","volume":"10","author":"Liu C.","year":"2019","unstructured":"Liu C.; Liu Y.; He J.; Mu R.; Di Y.; Shen N.; Liu X.; Gao X.; Wang J.; Chen T.; Fang T.; Li H.; Tian F.; Liraglutide increases VEGF expression via CNPY2-PERK pathway induced by hypoxia\/reoxygenation injury. Front Pharmacol  2019,10,789","journal-title":"Front Pharmacol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yjmcc.2019.04.018","volume":"132","author":"Yin W.","year":"2019","unstructured":"Yin W.; Guo J.; Zhang C.; Alibhai F.J.; Li S.H.; Billia P.; Wu J.; Yau T.M.; Weisel R.D.; Li R.K.; Knockout of Canopy 2 activates p16INK4a pathway to impair cardiac repair. J Mol Cell Cardiol  2019,132,36-48","journal-title":"J Mol Cell Cardiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccep.2018.11.001","volume":"11","author":"Snipelisky D.","year":"2019","unstructured":"Snipelisky D.; Chaudhry S.P.; Stewart G.C.; The many faces of heart failure. Card Electrophysiol Clin  2019,11(1),11-20","journal-title":"Card Electrophysiol Clin"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"Frey N.","year":"2004","unstructured":"Frey N.; Katus H.A.; Olson E.N.; Hill J.A.; Hypertrophy of the Heart. Circulation  2004,109(13),1580-1589","journal-title":"Circulation"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/eurheartj\/ehv294","volume":"36","author":"Guo J.","year":"2015","unstructured":"Guo J.; Mihic A.; Wu J.; Zhang Y.; Singh K.; Dhingra S.; Weisel R.D.; Li R.K.; Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy. Eur Heart J  2015,36(37),2530-2540","journal-title":"Eur Heart J"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41374-020-00508-y","volume":"101","author":"Yang W.","year":"2021","unstructured":"Yang W.; Liu L.; Wei Y.; Fang C.; Liu S.; Zhou F.; Li Y.; Zhao G.; Guo Z.; Luo Y.; Li L.; Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: A plausible role of adropin. Lab Invest  2021,101(3),369-380","journal-title":"Lab Invest"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2022.03.008","volume":"603","author":"Li J.","year":"2022","unstructured":"Li J.; Huang L.; Xiong W.; Qian Y.; Song M.; Aerobic exercise improves non-alcoholic fatty liver disease by down-regulating the protein expression of the CNPY2-PERK pathway. Biochem Biophys Res Commun  2022,603,35-40","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2001571","DOI":"10.1002\/adhm.202001571","volume":"10","author":"Poustchi F.","year":"2021","unstructured":"Poustchi F.; Amani H.; Ahmadian Z.; Niknezhad S.V.; Mehrabi S.; Santos H.A.; Shahbazi M.A.; Combination therapy of killing diseases by injectable hydrogels: From concept to medical applications. Adv Healthc Mater  2021,10(3),2001571","journal-title":"Adv Healthc Mater"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3804979","volume":"2018","author":"Sun M.S.","year":"2018","unstructured":"Sun M.S.; Jin H.; Sun X.; Huang S.; Zhang F.L.; Guo Z.N.; Yang Y.; Free radical damage in ischemia-reperfusion injury: An obstacle in acute ischemic stroke after revascularization therapy. Oxid Med Cell Longev  2018,2018,1-17","journal-title":"Oxid Med Cell Longev"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"609693","DOI":"10.3389\/fphar.2021.609693","volume":"12","author":"Zhao L.","year":"2021","unstructured":"Zhao L.; Li H.; Gao Q.; Xu J.; Zhu Y.; Zhai M.; Zhang P.; Shen N.; Di Y.; Wang J.; Chen T.; Huang M.; Sun J.; Liu C.; Berberine attenuates cerebral ischemia-reperfusion injury induced neuronal apoptosis by down-regulating the CNPY2 signaling pathway. Front Pharmacol  2021,12,609693","journal-title":"Front Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s41418-021-00907-8","volume":"29","author":"Rong Y.","year":"2022","unstructured":"Rong Y.; Fan J.; Ji C.; Wang Z.; Ge X.; Wang J.; Ye W.; Yin G.; Cai W.; Liu W.; USP11 regulates autophagy-dependent ferroptosis after spinal cord ischemia-reperfusion injury by deubiquitinating Beclin 1. Cell Death Differ  2022,29(6),1164-1175","journal-title":"Cell Death Differ"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1111\/jcmm.14688","volume":"23","author":"Zhao L.","year":"2019","unstructured":"Zhao L.; Zhai M.; Yang X.; Guo H.; Cao Y.; Wang D.; Li P.; Liu C.; Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia\u2010reperfusion injury by targeting the CNPY2\u2010endoplasmic reticulum stress signalling. J Cell Mol Med  2019,23(12),8173-8183","journal-title":"J Cell Mol Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3390\/ijms21061961","volume":"21","author":"Taguchi T.","year":"2020","unstructured":"Taguchi T.; Ikuno M.; Yamakado H.; Takahashi R.; Animal model for prodromal Parkinson\u2019s Disease. Int J Mol Sci  2020,21(6),1961","journal-title":"Int J Mol Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"Cerri S.","year":"2019","unstructured":"Cerri S.; Mus L.; Blandini F.; Parkinson\u2019s disease in women and men: What\u2019s the difference? J Parkinsons Dis  2019,9(3),501-515","journal-title":"J Parkinsons Dis"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"118159","DOI":"10.1016\/j.lfs.2020.118159","volume":"259","author":"Yang L.","year":"2020","unstructured":"Yang L.; Zhang X.; Li S.; Wang H.; Zhang X.; Liu L.; Xie A.; Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson\u2019s disease through Akt\/GSK3\u03b2 signaling pathway. Life Sci  2020,259,118159","journal-title":"Life Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ajps.2019.04.003","volume":"15","author":"Xiong S.","year":"2020","unstructured":"Xiong S.; Liu W.; Zhou Y.; Mo Y.; Liu Y.; Chen X.; Pan H.; Yuan D.; Wang Q.; Chen T.; Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation. Asian J Pharm Sci  2020,15(4),518-528","journal-title":"Asian J Pharm Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"10242","DOI":"10.18632\/aging.102451","volume":"11","author":"Chen L.","year":"2019","unstructured":"Chen L.; Xu S.; Wu T.; Shao Y.; Luo L.; Zhou L.; Ou S.; Tang H.; Huang W.; Guo K.; Xu J.; Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP\/PS1 transgenic mice. Aging  2019,11(22),10242-10251","journal-title":"Aging"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/1567202618666210531141833","volume":"18","author":"Chu M.","year":"2021","unstructured":"Chu M.; Liu H.; Xiong Z.; Ju C.; Zhao L.; Li K.; Tian S.; Gu P.; Canopy fibroblast growth factor signaling regulator 2 (CNPY2) inhibits neuron apoptosis in parkinson\u2019s disease via the AKT\/GSK3\u03b2 pathway. Curr Neurovasc Res  2021,18(1),102-112","journal-title":"Curr Neurovasc Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1248\/bpb.b17-00342","volume":"40","author":"Kaneko M.","year":"2017","unstructured":"Kaneko M.; Imaizumi K.; Saito A.; Kanemoto S.; Asada R.; Matsuhisa K.; Ohtake Y.; ER stress and disease: Toward prevention and treatment. Biol Pharm Bull  2017,40(9),1337-1343","journal-title":"Biol Pharm Bull"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3462530","volume":"2019","author":"Chen X.","year":"2019","unstructured":"Chen X.; Guo X.; Ge Q.; Zhao Y.; Mu H.; Zhang J.; ER stress activates the NLRP3 inflammasome: A novel mechanism of atherosclerosis. Oxid Med Cell Longev  2019,2019,1-18","journal-title":"Oxid Med Cell Longev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nsmb.3458","volume":"24","author":"Hong F.","year":"2017","unstructured":"Hong F.; Liu B.; Wu B.X.; Morreall J.; Roth B.; Davies C.; Sun S.; Diehl J.A.; Li Z.; CNPY2 is a key initiator of the PERK\u2013CHOP pathway of the unfolded protein response. Nat Struct Mol Biol  2017,24(10),834-839","journal-title":"Nat Struct Mol Biol"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557523666230601094149","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/217520\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557523666230601094149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T14:52:32Z","timestamp":1707749552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/217520\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557523666230601094149","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}